clinical trial · NCT06169397
An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Xentria, Inc.·phase2·enrolling by invitation·n = 94
Pulmonary SarcoidosisXTMAB-16
brief summary
Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
started
Mar 1, 2024
primary completion
Jan 1, 2029
completion
Jan 1, 2029
last updated
Jul 9, 2025
official title
A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol